Capabilities
Active Pharmaceutical Ingredients
Product
Facilities
Finished Dose Formulations
Product
Facilities
Antimicrobial Solutions
Novel Medicine
Featured Portfolio
Antimicrobial Stewardship Program
Exblifep
Research
Fighting AMR
Fighting AMR
Antimicrobial Stewardships
Company
About us
Careers
Our thoughts
Investor
Contact
Contact
Stockexchanges
Notice of Closure of Trading Window_June 2021
June 1, 2021
Outcome of EGM_E-Voting Results_June 2021
June 1, 2021
Proceedings of the EGM_June 29, 2021
June 1, 2021
Intimation under Regulation 30_May 2021
May 1, 2021
Board Meeting Intimation_May 22, 2021
May 1, 2021
Outcome of Board Meeting_May 22, 2021
May 1, 2021
Newspaper Publication_Financial Results_March 31, 2021
May 1, 2021
Notice of closure of Trading window-March 31,2021
March 31, 2021
Corporate Governance Report for the Quarter ended March 2021
March 31, 2021
Certificate under Regulation 7(3) for the half year ended-BSE March 31,2021
March 31, 2021
Certificate under Regulation 7(3) for the half year ended-NSE March 31,2021
March 31, 2021
Certificate under Regulation 74(5)_March 31, 2021
March 31, 2021
Statement of Investor Complaints_March 31, 2021
March 31, 2021
Certificate under Regulation 40(9)_March 31, 2021
March 31, 2021
Reconciliation of Share Capital Audit Report_March 31, 2021
March 31, 2021
Board Meeting Intimation - February 09, 2021
February 9, 2021
Previous
1
...
Next
22 / 36